Pharmacy Search
Vertice Login
Menu
close

Medmonitor

An up-to-date timeline of U.S. Food and Drug Administration (FDA) approvals that could potentially impact workers' compensation. These include new drug and indication approvals, new dosages or formulations of existing products, and generics introduced to the market. Click through the interactive timeline below, or select the comprehensive list view.
← Back to Medmonitor

Medication Type: Gastrointestinal

Voquezna (vonoprazan fumarate) tablets

Approval Date: Nov 2023

Note: New Product

Indicated for erosive esophagitis and the relief of heartburn associated with erosive esophagitis

Velsipity™ (estrasimod) tablets

Approval Date: Oct 2023

Note: New Product

Indicated for the treatment of moderate to severe ulcerative colitis

Medication Name

Approval Date

Category

Description

Voquezna (vonoprazan fumarate) tablets

Nov 2023

Indicated for erosive esophagitis and the relief of heartburn associated with erosive esophagitis

Note: New Product

Velsipity™ (estrasimod) tablets

Oct 2023

Indicated for the treatment of moderate to severe ulcerative colitis

Note: New Product
lockenvelopephone-handsetmagnifiermenucross-circle